FOLD
Amicus Therapeutics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
FOLD fundamentals
Amicus Therapeutics (FOLD) released its earnings on Nov 4, 2025: revenue was 169.06M (YoY +19.46%), beat estimates; EPS was 0.06 (YoY -40.00%), missed estimates.
Revenue / YoY
169.06M
+19.46%
EPS / YoY
0.06
-40.00%
Report date
Nov 4, 2025
FOLD Earnings Call Summary for Q3,2025
- Revenue Growth: Q3 revenue up 19% to $169.1M, driven by 13% Galafold patient growth and 45% Pompe revenue increase.
- Profitability Milestone: First quarter of GAAP net income ($17.3M) and positive cash flow generation.
- Pompe Momentum: 50-65% full year growth guidance, with 4x patient switch rate in U.S. vs. 2024.
- Pipeline Progress: DMX-200 Phase III >90% enrolled, targeting FSGS approval.
- Strategic Targets: $1B combined Galafold/Pompe sales by 2028, >50% Pompe market share at peak.
EPS
Revenue
Revenue & Expenses
FOLD has released its 2025 Q3 earnings report, with revenue of 169.06M, reflecting a YoY change of 19.46%, and net profit of 17.31M, showing a YoY change of 357.19%. The Sankey diagram below clearly presents FOLD's revenue sources and cost distribution.
Key Indicators
Amicus Therapeutics (FOLD) key financial stats and ratios, covering profitability, financial health, and leverage.
Amicus Therapeutics (FOLD)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Amicus Therapeutics (FOLD)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Amicus Therapeutics (FOLD)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Amicus Therapeutics (FOLD) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Amicus Therapeutics (FOLD) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What does Amicus Therapeutics do and what are its main business segments?Did Amicus Therapeutics beat or miss consensus estimates last quarter?What were the key takeaways from Amicus Therapeutics’s earnings call?What guidance did Amicus Therapeutics's management provide for the next earnings period?What is Amicus Therapeutics's latest dividend and current dividend yield?What is the revenue and EPS growth rate for Amicus Therapeutics year over year?What is the market's earnings forecast for Amicus Therapeutics next quarter?What is Amicus Therapeutics's gross profit margin?
